AvantGuard Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $15M

  • Investors
  • 17

AvantGuard General Information

Description

Developer of a topical skin care technology designed to treat skin conditions by strengthening the immune response, disrupting established biofilms, and restoring microbial balance. The company offers a proprietary delivery system for hypochlorous acid that enables high concentrations to be safely applied to the skin in a slow-release format, enabling dermatology and skin care users to manage conditions such as acne, eczema, and rosacea.

Contact Information

Website
www.avantguardinc.com
Formerly Known As
Halomine
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 95 Brown Road
  • Room 289 Ithaca
  • New York, NY 14850-1294
  • United States
+1 (518)
Primary Industry
Biotechnology
Other Industries
Specialty Chemicals
Vertical(s)
Life Sciences
Corporate Office
  • 95 Brown Road
  • Room 289 Ithaca
  • New York, NY 14850-1294
  • United States
+1 (518)

AvantGuard Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AvantGuard Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
26. Later Stage VC (Series A) $15M Upcoming Pre-Clinical Trials
25. Early Stage VC In Progress Pre-Clinical Trials
24. Seed Round 24-Apr-2026 Completed Pre-Clinical Trials
23. Seed Round 05-Jan-2024 Completed Pre-Clinical Trials
22. Grant 07-Jun-2023 Completed Pre-Clinical Trials
21. Seed Round 11-May-2023 Completed Product In Beta Test
20. Grant 15-Feb-2023 Completed Product In Beta Test
19. Grant 31-Dec-2022 Completed Product In Beta Test
18. Grant 01-Dec-2022 $2.7M $1.59M Completed Product In Beta Test
17. Grant 20-May-2022 $3.64M $1.59M Completed Product Development
To view AvantGuard’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

AvantGuard Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a topical skin care technology designed to treat skin conditions by strengthening the immune response, disr
Biotechnology
New York, NY
8 As of 2026

Paris, France
 

Slough, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AvantGuard Competitors (2)

One of AvantGuard’s 2 competitors is L'Oreal, a Corporation company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
L'Oreal Corporation Paris, France
Reckitt Benckiser Group Corporation Slough, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

AvantGuard Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

AvantGuard Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025249078-A1 Topical and surface disinfectant compositions Pending 03-Apr-2024
WO-2025212941-A1 Topical and surface disinfectant compositions Pending 03-Apr-2024
AU-2023352864-A1 Disinfectant compositions and methods thereof Pending 27-Sep-2022
EP-4594377-A2 Disinfectant compositions and methods thereof Pending 27-Sep-2022
EP-4594377-A4 Disinfectant compositions and methods thereof Pending 27-Sep-2022 A01P1/00
To view AvantGuard’s complete patent history, request access »

AvantGuard Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AvantGuard Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Blue Ledge Capital Venture Capital Minority
IndieBio Accelerator/Incubator
Empire State Development Government
United States Department of War Government
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial

AvantGuard FAQs

  • When was AvantGuard founded?

    AvantGuard was founded in 2018.

  • Where is AvantGuard headquartered?

    AvantGuard is headquartered in New York, NY.

  • What is the size of AvantGuard?

    AvantGuard has 8 total employees.

  • What industry is AvantGuard in?

    AvantGuard’s primary industry is Biotechnology.

  • Is AvantGuard a private or public company?

    AvantGuard is a Private company.

  • What is AvantGuard’s current revenue?

    The current revenue for AvantGuard is .

  • How much funding has AvantGuard raised over time?

    AvantGuard has raised $6.14M.

  • Who are AvantGuard’s investors?

    National Institutes of Health, Blue Ledge Capital, IndieBio, Empire State Development, and United States Department of War are 5 of 17 investors who have invested in AvantGuard.

  • Who are AvantGuard’s competitors?

    L'Oreal and Reckitt Benckiser Group are competitors of AvantGuard.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process